vs

Side-by-side financial comparison of Kiniksa Pharmaceuticals International, plc (KNSA) and MACOM Technology Solutions Holdings, Inc. (MTSI). Click either name above to swap in a different company.

MACOM Technology Solutions Holdings, Inc. is the larger business by last-quarter revenue ($271.6M vs $202.1M, roughly 1.3× Kiniksa Pharmaceuticals International, plc). MACOM Technology Solutions Holdings, Inc. runs the higher net margin — 18.0% vs 7.0%, a 10.9% gap on every dollar of revenue. On growth, Kiniksa Pharmaceuticals International, plc posted the faster year-over-year revenue change (65.0% vs 24.5%). Kiniksa Pharmaceuticals International, plc produced more free cash flow last quarter ($53.3M vs $30.0M). Over the past eight quarters, Kiniksa Pharmaceuticals International, plc's revenue compounded faster (59.1% CAGR vs 22.4%).

Kiniksa Pharmaceuticals International plc is a global biopharmaceutical firm focused on discovering, developing and commercializing targeted therapies for patients with unmet medical needs, primarily in autoimmune, inflammatory and rare disease segments. It operates across major markets including North America, Europe and Asia, advancing a pipeline of clinical-stage and approved treatment candidates.

MACOM Technology Solutions, Inc. is an American developer and producer of radio, microwave, and millimeter wave semiconductor devices and components. The company is headquartered in Lowell, Massachusetts, and in 2005 was Lowell's largest private employer. MACOM is certified to the ISO 9001 international quality standard and ISO 14001 environmental standard. The company has design centers and sales offices in North America, Europe, Asia and Australia.

KNSA vs MTSI — Head-to-Head

Bigger by revenue
MTSI
MTSI
1.3× larger
MTSI
$271.6M
$202.1M
KNSA
Growing faster (revenue YoY)
KNSA
KNSA
+40.4% gap
KNSA
65.0%
24.5%
MTSI
Higher net margin
MTSI
MTSI
10.9% more per $
MTSI
18.0%
7.0%
KNSA
More free cash flow
KNSA
KNSA
$23.3M more FCF
KNSA
$53.3M
$30.0M
MTSI
Faster 2-yr revenue CAGR
KNSA
KNSA
Annualised
KNSA
59.1%
22.4%
MTSI

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
KNSA
KNSA
MTSI
MTSI
Revenue
$202.1M
$271.6M
Net Profit
$14.2M
$48.8M
Gross Margin
89.6%
55.9%
Operating Margin
9.8%
15.9%
Net Margin
7.0%
18.0%
Revenue YoY
65.0%
24.5%
Net Profit YoY
259.8%
129.1%
EPS (diluted)
$0.18
$0.64

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
KNSA
KNSA
MTSI
MTSI
Q1 26
$271.6M
Q4 25
$202.1M
$261.2M
Q3 25
$180.9M
$252.1M
Q2 25
$156.8M
$235.9M
Q1 25
$137.8M
$218.1M
Q4 24
$122.5M
Q3 24
$112.2M
$200.7M
Q2 24
$108.6M
$190.5M
Net Profit
KNSA
KNSA
MTSI
MTSI
Q1 26
$48.8M
Q4 25
$14.2M
$45.1M
Q3 25
$18.4M
$36.5M
Q2 25
$17.8M
$31.7M
Q1 25
$8.5M
$-167.5M
Q4 24
$-8.9M
Q3 24
$-12.7M
$29.4M
Q2 24
$-3.9M
$19.9M
Gross Margin
KNSA
KNSA
MTSI
MTSI
Q1 26
55.9%
Q4 25
89.6%
54.5%
Q3 25
88.8%
55.3%
Q2 25
88.1%
55.2%
Q1 25
87.0%
53.7%
Q4 24
85.4%
Q3 24
82.1%
54.7%
Q2 24
88.7%
53.2%
Operating Margin
KNSA
KNSA
MTSI
MTSI
Q1 26
15.9%
Q4 25
9.8%
15.2%
Q3 25
13.3%
14.9%
Q2 25
12.9%
14.8%
Q1 25
9.6%
8.0%
Q4 24
-15.7%
Q3 24
-8.6%
13.7%
Q2 24
-0.1%
10.4%
Net Margin
KNSA
KNSA
MTSI
MTSI
Q1 26
18.0%
Q4 25
7.0%
17.3%
Q3 25
10.2%
14.5%
Q2 25
11.4%
13.4%
Q1 25
6.2%
-76.8%
Q4 24
-7.3%
Q3 24
-11.3%
14.7%
Q2 24
-3.6%
10.5%
EPS (diluted)
KNSA
KNSA
MTSI
MTSI
Q1 26
$0.64
Q4 25
$0.18
$0.67
Q3 25
$0.23
$0.48
Q2 25
$0.23
$0.42
Q1 25
$0.11
$-2.30
Q4 24
$-0.11
Q3 24
$-0.18
$0.40
Q2 24
$-0.06
$0.27

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
KNSA
KNSA
MTSI
MTSI
Cash + ST InvestmentsLiquidity on hand
$414.1M
$768.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$567.6M
$1.4B
Total Assets
$763.6M
$2.1B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
KNSA
KNSA
MTSI
MTSI
Q1 26
$768.5M
Q4 25
$414.1M
$786.0M
Q3 25
$352.1M
$735.2M
Q2 25
$307.8M
$681.5M
Q1 25
$268.3M
$656.5M
Q4 24
$243.6M
Q3 24
$223.8M
$581.9M
Q2 24
$218.8M
$521.5M
Stockholders' Equity
KNSA
KNSA
MTSI
MTSI
Q1 26
$1.4B
Q4 25
$567.6M
$1.3B
Q3 25
$535.4M
$1.3B
Q2 25
$495.0M
$1.2B
Q1 25
$457.5M
$1.2B
Q4 24
$438.4M
Q3 24
$437.0M
$1.1B
Q2 24
$435.1M
$1.1B
Total Assets
KNSA
KNSA
MTSI
MTSI
Q1 26
$2.1B
Q4 25
$763.6M
$2.1B
Q3 25
$712.3M
$2.0B
Q2 25
$661.1M
$1.9B
Q1 25
$599.3M
$1.8B
Q4 24
$580.6M
Q3 24
$555.3M
$1.8B
Q2 24
$542.4M
$1.7B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
KNSA
KNSA
MTSI
MTSI
Operating Cash FlowLast quarter
$53.9M
$42.9M
Free Cash FlowOCF − Capex
$53.3M
$30.0M
FCF MarginFCF / Revenue
26.4%
11.0%
Capex IntensityCapex / Revenue
0.3%
4.8%
Cash ConversionOCF / Net Profit
3.80×
0.88×
TTM Free Cash FlowTrailing 4 quarters
$136.4M
$161.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
KNSA
KNSA
MTSI
MTSI
Q1 26
$42.9M
Q4 25
$53.9M
$69.6M
Q3 25
$33.7M
$60.4M
Q2 25
$28.1M
$38.7M
Q1 25
$22.3M
$66.7M
Q4 24
$18.8M
Q3 24
$-2.2M
$62.3M
Q2 24
$5.2M
$49.0M
Free Cash Flow
KNSA
KNSA
MTSI
MTSI
Q1 26
$30.0M
Q4 25
$53.3M
$49.4M
Q3 25
$33.0M
$51.6M
Q2 25
$27.9M
$30.5M
Q1 25
$22.2M
$61.3M
Q4 24
$18.6M
Q3 24
$57.1M
Q2 24
$41.5M
FCF Margin
KNSA
KNSA
MTSI
MTSI
Q1 26
11.0%
Q4 25
26.4%
18.9%
Q3 25
18.2%
20.5%
Q2 25
17.8%
12.9%
Q1 25
16.1%
28.1%
Q4 24
15.2%
Q3 24
28.5%
Q2 24
21.8%
Capex Intensity
KNSA
KNSA
MTSI
MTSI
Q1 26
4.8%
Q4 25
0.3%
7.7%
Q3 25
0.4%
3.5%
Q2 25
0.1%
3.5%
Q1 25
0.1%
2.4%
Q4 24
0.2%
Q3 24
0.0%
2.6%
Q2 24
0.0%
3.9%
Cash Conversion
KNSA
KNSA
MTSI
MTSI
Q1 26
0.88×
Q4 25
3.80×
1.54×
Q3 25
1.83×
1.65×
Q2 25
1.58×
1.22×
Q1 25
2.61×
Q4 24
Q3 24
2.12×
Q2 24
2.46×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

KNSA
KNSA

Segment breakdown not available.

MTSI
MTSI

Industrial Defense$117.7M43%
Data Center$85.8M32%
Telecom$68.1M25%

Related Comparisons